로딩 중…
지수 로딩 중…
ORIENTBIO Inc.
002630· KOSPI· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩864-4.21%
2026-06-19
Price Chart
ORIENTBIO Inc.-49.12%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 51.23B KRW |
| Revenue | 29.40B KRW |
| Net Income | -9.09B KRW |
| Total Assets | 84.78B KRW |
| Net Assets | 71.85B KRW |
| Employees | 106 |
| Value | |
| P/B | 0.71x |
| P/S | 1.74x |
| EV/EBITDA | 56.14x |
| FCF Yield | -12.00% |
| Profitability | |
| ROE | -12.66% |
| ROA | -10.72% |
| Op. Margin | 2.71% |
| Revenue Growth | 4.97% |
| Earnings Growth | -141.23% |
| Financial Health | |
| Debt Ratio | 18.00% |
| Total Debt | 0 KRW |
| FCF | -6.15B KRW |
| Cash | 6.53B KRW |
| Current Ratio | 11.26x |
| Net Debt/EBITDA | -8.20x |
| Performance | |
| 1Y Return | -49.12% |
| 1M Return | -10.56% |
| From 52W High | -56.76% |
| 1Y MDD | -70.16% |
| Trading | |
| Volume | 223,325 shares |
| Foreign Own. | 1.01% |
| Per Share | |
| EPS | -138 KRW |
| BPS | 1,142 KRW |
Company Info
Established in 1959, the company merged with Biogenomics in 2003 and spun off its watch business in 2005. It operates in laboratory animal production and life science research and development, holding a technical alliance with Charles River Laboratories. The company produces high-quality biological resources using Korea's largest land area and breeding facilities, and also runs a laboratory equipment CRO business. It is dedicated to enhancing technological competitiveness through bio-industry facility construction, advanced equipment development, and clinical trials for new hair loss drugs. Orient Bio is headquartered in Seongnam-si, Gyeonggi.